Fully Integrated CDMO Services

One premier location for cell line development, process development, and manufacturing. Built for end-to-end services, and globally known for tackling some of the most challenging biologics projects.

Under one roof, KBI and Selexis provide services from cell line transfection through to cGMP drug manufacturing with Selexis’ specialized high-titer mammalian cell line development technologies and services and KBI’s cGMP bulk drug manufacturing for clinical and commercial requirements.

The fully integrated Selexis and KBI development platform has supported more than 60 clinical development programs with high productivity and robust product quality. The two companies have developed a seamless approach to optimize the client experience.